Vis enkel innførsel

dc.contributor.authorGerdts, Eva
dc.contributor.authorSudano, Isabella
dc.contributor.authorBrouwers, Sofie
dc.contributor.authorBorghi, Claudio
dc.contributor.authorBruno, RM
dc.contributor.authorCeconi, Claudio
dc.contributor.authorCornelissen, Veronique
dc.contributor.authorDievart, Francois
dc.contributor.authorFerrini, Marc
dc.contributor.authorKahan, Thomas
dc.contributor.authorLøchen, Maja-Lisa
dc.contributor.authorMaas, Angela H.E.M.
dc.contributor.authorMahfoud, Felix
dc.contributor.authorMihailidou, Anastasia Susie
dc.contributor.authorMoholdt, Trine
dc.contributor.authorParati, Gianfranco
dc.contributor.authorde Simone, Giovanni
dc.date.accessioned2022-12-30T14:24:51Z
dc.date.available2022-12-30T14:24:51Z
dc.date.created2022-11-18T19:14:29Z
dc.date.issued2022
dc.identifier.issn0195-668X
dc.identifier.urihttps://hdl.handle.net/11250/3040121
dc.description.abstractThere is strong evidence that sex chromosomes and sex hormones influence blood pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities differentially in females and males with essential arterial hypertension. The risk for CV disease increases at a lower BP level in females than in males, suggesting that sex-specific thresholds for diagnosis of hypertension may be reasonable. However, due to paucity of data, in particularly from specifically designed clinical trials, it is not yet known whether hypertension should be differently managed in females and males, including treatment goals and choice and dosages of antihypertensive drugs. Accordingly, this consensus document was conceived to provide a comprehensive overview of current knowledge on sex differences in essential hypertension including BP development over the life course, development of hypertension, pathophysiologic mechanisms regulating BP, interaction of BP with CV risk factors and co-morbidities, hypertension-mediated organ damage in the heart and the arteries, impact on incident CV disease, and differences in the effect of antihypertensive treatment. The consensus document also highlights areas where focused research is needed to advance sex-specific prevention and management of hypertension.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleSex differences in arterial hypertensionen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1093/eurheartj/ehac470
dc.identifier.cristin2076641
dc.source.journalEuropean Heart Journalen_US
dc.source.pagenumber4777-4788en_US
dc.identifier.citationEuropean Heart Journal. 2022, 43 (46), 4777-4788.en_US
dc.source.volume43en_US
dc.source.issue46en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal